| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |